H.P. Acthar Gel (repository corticotropin injection) / Mallinckrodt  >>  Phase 4
Welcome,         Profile    Billing    Logout  

4 Trials

   Remove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
H.P. Acthar Gel (repository corticotropin injection) / Mallinckrodt
FACT, NCT05546047: A Study of Acthar Gel Alone or With Tacrolimus to Reduce Proteinuria in Fibrillary Glomerulopathy Patients

Active, not recruiting
4
34
US
Acthar Gel 80 UNT/ML Injectable Solution, Tacrolimus 1.0 mg
NephroNet, Inc., Mallinckrodt
Fibrillary Glomerulonephritis
10/23
10/24
NCT02541955: Use of Acthar in Rheumatoid Arthritis (RA) Related Flares

Recruiting
4
40
US
Acthar, Repository corticotropin injection
Veena Ranganath, MD, MS
Rheumatoid Arthritis (RA)
12/24
12/25
NCT02226341: ACTHar in the Treatment of Lupus Nephritis

Recruiting
4
20
US
CellCept, Mycophenolate Mofetil, ACTHar gel, ACTHar, H.P. ACTHar Gel, Repository corticotropin
Columbia University
Lupus Nephritis
01/24
07/24
NCT02523092: Use of CXCL9 as a Biomarker of Acthar Efficacy

Recruiting
4
14
US
Acthar gel, Acthar
University of California, San Francisco, Mallinckrodt
Sarcoidosis
12/25
12/26

Download Options